All News

#EULAR2022 Rebuttal! 💻⚕️ Telemedicine improves patient-doctor relationship Supplements F2F visits, making them more efficient Patients are communicating, texting all the time Can AI help improve early pt communication? @ChristianDejaco @RheumNow

Eric Dein ericdeinmd ( View Tweet)

Some / most of promises of #JAKi are fulfilled. Efficacy, adherence = on mono vs combination Rx with MTX. But some emerging safety issues. NK cells reduce inflammation of NK cells on fibroblasts re other MOA. @eular #EULAR2022 ⁦@RheumNow⁩ The promise of #JAKi I RA https://t.co/8Ry3vVMyzO
Janet Pope Janetbirdope ( View Tweet)
Gilbert et al. RA assoc increased risk hospitalisation or death from COVID-19 1.53 (1.20, 1.94). RA-ILD assoc even greater risk hospitalisation or death multivariable HR 2.84 [95% CI 1.64-4.91] @RheumNow #EULAR2022 OP0251 https://t.co/h1jzAV6xNR https://t.co/7E1EzAKCDv

Links:

Richard Conway RichardPAConway ( View Tweet)
Perrot et al. Factors assoc severe COVID in SpA. corticosteroid intake (3.15 [1.46-6.76]), age (OR=1.06 [1.04-1.08]) while anti-TNF (OR=0.26 [0.09-0.78]) was protective @RheumNow #EULAR2022 OP0254 https://t.co/bIiEW6efQ2

Links:

Richard Conway RichardPAConway ( View Tweet)

A new finding - antimalarials improve safety w bDMARDs & #JAKi and reduce CV events and improve drug survival #Bestinclass. POS0242 @RheumNow @eular_org #EULAR2022 Neat. Safe, inexpensive and monitor eyes 👀 https://t.co/Ea4VA9vqwe
Janet Pope Janetbirdope ( View Tweet)
Large 5 country cohort study - No increased risk of hematologic malignancies (lymphoid or myeloid) in PsA pts treated with TNFi. In PsA overall compared to general population - moderately increased underlying risk of hematologic malignancies. @RheumNow #EULAR2022 ABST#OP0257 https://t.co/P846RupitR
Robert B Chao, MD doctorRBC ( View Tweet)
#OP0783 #EULAR2022 A study in Spain (N=72) of #Sjogren pts showed Pathologic US of salivary glands were associated with Ro52+, raised IgG, early menopause & lack Mediterranean diet. Smoking was protective but wide Confidence Interval. I wont promote smoking though @RheumNow https://t.co/kn4X4oFGzK
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Female PsA patients on TNFi have reduced treatment effectiveness, LDA (vs males). #EULAR2022 POS0077 @RheumNow https://t.co/EwDwxUarNb https://t.co/W5xgQlrnlF

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the future of rheumatology. In amongst the trash talking, here are some highlights @RheumNow

David Liew drdavidliew ( View Tweet)

#ClinicalPearl. Why do doctors prescribe #JAKi in RA? Efficacy, fast onset, X-ray inhibition, can work as monotherapy, remission - in order of diminishing frequency BUT I will add access and oral (convenience). POS0680 @RheumNow @eular_org #EULAR2022 https://t.co/XHtNqguqvh
Janet Pope Janetbirdope ( View Tweet)
#EULAR2022 Telemedicine: PROs 💻Triage, reduce wait time, direct other specialty referral 💻High agreement w F2F evaluation (79-97%) 💻Saves resources, react quickly to minor flare 💻Better adherence @RheumNow

Eric Dein ericdeinmd ( View Tweet)

BTKi are they effective in #rheumatology? Seem to work in preclinical models of inflammation but so far clinical results seem disappointing #POS0397 @RheumNow @eular_org #EULAR2022 https://t.co/2NjcMnU1d6
Janet Pope Janetbirdope ( View Tweet)
#EULAR2022 R Landewe: Anti-Telemedicine 🩺Rheumatology about long-term relationship & communication 🩺"Telemedicine impoverishes visit" by only exchanging information @Rheumnow

Eric Dein ericdeinmd ( View Tweet)

#POS0752 #EULAR2022 Is there difference btw childhood- vs adult-onset #lupus?A cohort study of claims database >10,000 pts showed: Children had higher activity & more likely to receive immunosuppressant Some activities persisted Useful to bear in transition clinic @RheumNow https://t.co/KVHZUgAOlV
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Inflammation (ESR >20 and cardiovascular risk scores) in AxSpA pts associated with incident hypertension. csDMARD may be associated with HTN NSAID and biologics not associated with incident HTN @RheumNow #EULAR2022 ABST#POS0154 https://t.co/5pYjXrpCec
Robert B Chao, MD doctorRBC ( View Tweet)
#PEARLS by EULAR President Prof Iagnocco: 1. Enthesitis can be present in 25% of #SLE patients 2. Erosions can be common and independent of ACPA/RF status 3. Active myositis is indistinguishable from IIM 4. Don't forget pain osteonecrosis/osteomyelitis #EULAR2022 @rheumnow https://t.co/8uWCw9rEve
TheDaoIndex KDAO2011 ( View Tweet)
#OP0249 #EULAR2022 Dr Machado presented pooled data >5000 pts. Poor #COVID outcomes in Pso, PsA and AxSpa were associated with the usual suspects: Age, male, high disease activity and comorbidities. No specific bDMARDs was associated. Good news for our patients @RheumNow https://t.co/itzmwqKCrH
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Staggering facts by Prof Vital on #SLE and SkM Sx’s: - 50% of first Sx’s is SkM - SkM Sx are in top 3 concerns for pts - 34% pts w/SkM Sx stopped working median 4 yrs - SkM damage clusters with CVD damage #EULAR2022 @rheumnow https://t.co/NXEW3XYCQZ
TheDaoIndex KDAO2011 ( View Tweet)
📲The great debate on Telemedicine 💻 R. Landewe warns us against "check box medicine" and its consequences on AxSpA overdiagnosis. @RheumNow #EULAR2022 https://t.co/Xwg0aAdHwE
Aurelie Najm AurelieRheumo ( View Tweet)
“#SLEDAI should be scored when there is joint swelling (not just tenderness)—note that only 48% of pts with tenderness will have u/s evidence of inflammation” – Prof E Vital #EULAR2022 @rheumnow https://t.co/hhsZ9wMAWs
TheDaoIndex KDAO2011 ( View Tweet)
×